Publication
Characterising ALS disease progression according to El Escorial and Gold Coast criteria.
Journal Paper/Review - Jun 2, 2022
de Jongh Adriaan D, Braun Nathalie, Weber Markus, van Es Michael A, Masrori Pegah, Veldink Jan H, Van Damme Philip, van den Berg Leonard H, van Eijk Ruben P A
Units
PubMed
Doi
Contact
Citation
de Jongh A, Braun N, Weber M, van Es M, Masrori P, Veldink J, Van Damme P, van den Berg L, van Eijk R. Characterising ALS disease progression according to El Escorial and Gold Coast criteria. J Neurol Neurosurg Psychiatry 2022; 93:865-870.
Type
Journal Paper/Review (English)
Journal
J Neurol Neurosurg Psychiatry 2022; 93
Publication Date
Jun 2, 2022
Issn Electronic
1468-330X
Pages
865-870
Brief description/objective
The Gold Coast criteria (GCC) have been proposed as a means of selecting patients for amyotrophic lateral sclerosis (ALS) clinical trials. We aimed to characterise disease progression according to the GCC.